AARTIDRUGS — Aarti Drugs Income Statement
0.000.00%
Last trade - 00:00
- IN₹46.35bn
- IN₹52.12bn
- IN₹27.16bn
- 91
- 22
- 65
- 67
C2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15,609 | 18,061 | 21,548 | 24,886 | 27,161 |
Cost of Revenue | |||||
Gross Profit | 3,272 | 4,170 | 6,155 | 5,212 | 5,146 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,926 | 15,893 | 17,673 | 22,061 | 24,569 |
Operating Profit | 1,684 | 2,168 | 3,875 | 2,825 | 2,591 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,310 | 1,853 | 3,690 | 2,700 | 2,242 |
Provision for Income Taxes | |||||
Net Income After Taxes | 898 | 1,414 | 2,804 | 2,050 | 1,664 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 898 | 1,414 | 2,804 | 2,050 | 1,663 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 898 | 1,414 | 2,804 | 2,050 | 1,663 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.24 | 14.8 | 30.1 | 22.1 | 18 |
Dividends per Share |